Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the closing of its ...
If you are interested in gaining professional development experience in the United States, applications are now open for the ...
Holding that there was no real delay, the Tribunal directed grant of section 80G approval. The decision stresses practical and reasonable interpretation of filing ...
SEBI strongly countered Sathe’s arguments. Senior advocate Chetan Kapadia, appearing for SEBI, read out transcripts of videos ...
Recognising the non-commercial nature of a long-standing charitable trust, the Tribunal condoned the delay. The registration application was sent back for reconsideration on ...
Markets regulator Securities and Exchange Board of India (SEBI) decided to integrate digital signature certificate (DSC) ...
China's top court has reiterated the ban on demanding betrothal gifts or any form of property under the pretext of marriage, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback